Defective medical device injury lawyer

A medical device claim differs from an ordinary product claim in one structural way: the device was implanted or used by a physician, on a patient who had a condition, under a federal regulatory scheme. That means causation has to be separated from the underlying illness, and it means the route by which the device reached the market can shape what claims are legally available at all. The explanted device, the operative records and the device identifiers are the evidence, and hospitals do not keep removed hardware indefinitely. Law Offices Of SRIS, P.C. has practiced since 1997 and handles injury claims in Virginia, Maryland, the District of Columbia, New Jersey and New York. To discuss a device injury, reach our location at (888) 437-7747.

On This Page

The regulatory pathway shapes the claim

Devices reach the United States market by different routes, and the route matters legally as well as clinically. Some are approved after a full premarket review of safety and effectiveness. Some are cleared on the basis of substantial equivalence to a device already on the market. Some are exempt from premarket review altogether.

Federal preemption doctrine treats these routes differently, and the practical consequence is that a claim which is available against one device may be restricted against another that does the same clinical job. This is one of the first questions to resolve in any device case, because it determines which theories can be pleaded, and it turns on documents — the regulatory file for the specific device — rather than on general expectation. How far the doctrine reaches, and what claims survive it, must be researched against the law of the jurisdiction where the case will be filed.

What a defect claim in this setting actually alleges

Three theories recur, and they require different proof.

Manufacturing defect — this unit departed from its own specification. It is proved by examining the explanted device against the specification and the manufacturing record, and it is often the theory least affected by preemption arguments because it alleges a departure from what the regulator approved rather than a challenge to it.

Design defect — the device was unreasonably dangerous as designed, whether through the materials chosen, a mechanism of wear or corrosion, or a failure mode inherent to the geometry. This is the theory most exposed to regulatory defenses.

Failure to warn — the risk that materialised was known or knowable and was not adequately communicated. In most jurisdictions the warning is owed to the implanting physician rather than directly to the patient, which makes the physician’s knowledge and testimony central. What the manufacturer knew, and when, is established through adverse event reporting, internal complaint files, post-market surveillance and any label revisions.

Preserving the device and the records

If the device has been or will be explanted, this is urgent. Hospitals and surgical centers frequently return removed hardware to the manufacturer for analysis, discard it under pathology retention schedules, or process it in a way that destroys the surfaces of interest. Once it is in the manufacturer’s possession, the claimant is dependent on the other side’s account of it.

Before an explant, written notice should go to the surgeon and the facility asking that the device be retained, not returned to the manufacturer, not cleaned or sterilised beyond what is clinically necessary, and released into a documented chain of custody. Photographs in situ and at removal are valuable. After an explant, ask immediately where the device went and put the request in writing, because pathology and facility retention periods are short.

The paper record matters as much: the operative reports for implant and revision, the implant log or device identification sticker recording manufacturer, model, catalogue and lot or serial number, imaging before and after, and the complete treatment record. Device identifiers are what connect the injury to a recall, a lot and a batch, and without them the case is materially weaker.

Causation is the contested ground

The patient had a condition serious enough to warrant a device. The defense begins there. It will argue that the outcome reflects the underlying disease, the natural history of the condition, surgical technique, patient anatomy, infection unrelated to the device, or non-compliance with post-operative instruction.

Answering that requires the medical record read as a timeline rather than a diagnosis list: the baseline before implantation, the interval of function, the onset and character of symptoms, imaging showing wear or migration or fracture, laboratory findings where a material response is alleged, and the findings at revision surgery. The explanted device examined against that timeline is what converts a clinical narrative into an engineering one.

Recalls, advisories and adverse event reporting

A recall or safety advisory covering the device, lot and date range is significant evidence and should be checked at the outset. So should the public adverse event reporting record for the device family, which can show a pattern of the same failure mode before the patient’s implantation.

Neither is decisive on its own. A recall still has to be connected to the specific unit and the specific injury, and manufacturers commonly argue that a field action reflects caution rather than defect. Equally, the absence of a recall does not defeat a claim; most device claims concern products that were never recalled. What these records do most reliably is establish notice and knowledge, which is the backbone of a failure-to-warn theory.

Who may be responsible

The device manufacturer is the usual defendant. A component supplier may be liable where the failure originates in a material or part. A reprocessor may be liable for a single-use device that was reprocessed. A distributor or facility may be liable in some circumstances, including where a device subject to a field action continued in use. Claims against the treating physician or hospital sound in medical negligence rather than product liability, follow different procedural rules, and in several of the states in which the firm practices require pre-suit certification or expert support — so whether a case is a product case, a malpractice case, or both is a threshold question with practical consequences for how and when it must be filed.

Available insurance coverage

Device manufacturers and suppliers carry products liability coverage, and a corporate defendant’s assets may matter independently of insurance. Where a healthcare provider is also a defendant, professional liability coverage responds instead and on different terms. Health plan reimbursement rights, hospital liens and government program recovery rights frequently attach to any settlement, and because device cases involve substantial medical spending those claims can be large. They should be identified before a settlement is structured rather than afterwards. Complete plan documents and policy forms are obtained rather than assumed.

Filing deadlines

Every injury claim is governed by a statute of limitations, and the periods differ by state and by claim type. For personal injury actions the period is two years in Virginia under Va. Code § 8.01-243(A), accruing at the date of injury; three years in Maryland under Md. Code, Cts. & Jud. Proc. § 5-101; three years in the District of Columbia under D.C. Code § 12-301(8); two years in New Jersey under N.J.S.A. 2A:14-2; and three years in New York under N.Y. C.P.L.R. § 214(5). These are general periods. Discovery rules, tolling for minors and incapacity, claims against government entities — the District imposes a six-month notice-of-claim requirement for claims against the District government — and claim-specific statutes can shorten or extend them. Do not rely on a general period for your own case; have the deadline confirmed on your facts.

Product claims can carry an additional constraint that ordinary injury claims do not. Some states limit claims by reference to the age of the product rather than the date of injury, and some apply particular accrual or discovery rules to defect claims. Because these provisions vary and can bar a claim that is otherwise timely, the deadline in a product case should be confirmed against the specific state and the specific product rather than assumed from the general injury period.

Device cases raise the discovery question more often than most, because the interval between implantation and recognized injury can be long and the patient may not have connected symptoms to the device. Where a claim is also framed against a healthcare provider, a different and often shorter set of procedural deadlines applies. Both should be assessed together at the outset.

Frequently Asked Questions

Does a recall mean I have a claim?

Not by itself, though it is significant. A recall shows the manufacturer identified a problem, and it supports notice and knowledge, but it still has to be connected to the specific device, lot and injury. The reverse is also true: most device claims involve products that were never recalled, so the absence of a recall does not end the analysis.

Why does the regulatory approval route matter?

Because federal preemption doctrine treats devices differently depending on how they reached the market. A theory available against a device cleared on one route may be restricted against a device approved on another, even where both perform the same clinical function. It is resolved from the regulatory file for the specific device and against the law of the jurisdiction where the case will be filed, and it is one of the first questions examined.

What happens to the device after it is removed?

Often it goes back to the manufacturer for analysis, or into pathology under a short retention schedule, or it is processed in a way that damages the surfaces that matter. Once the manufacturer holds it, you depend on their account of it. Written notice to the surgeon and facility before the operation, asking that it be retained and released into a documented chain of custody, is the step that prevents this.

I already had revision surgery and nobody kept the device. Is the case over?

Not automatically. Ask in writing where it went, because facilities and pathology departments sometimes still hold it, and manufacturers who received it may have retained it and produced an analysis report. Operative findings, imaging, the implant log and the treatment record all carry evidence. It is a weaker position than holding the device, and it is not necessarily a fatal one.

Who has to be warned about a device risk?

In most jurisdictions the warning is owed to the implanting physician rather than to the patient directly, on the basis that the physician exercises the clinical judgment. That makes the physician’s knowledge and testimony central to a failure-to-warn claim, alongside what the manufacturer knew from its own complaint files, post-market surveillance and adverse event reporting.

Is this a product case or a medical malpractice case?

Sometimes both, and the distinction has practical consequences. A claim that the device was defective is a product claim against the manufacturer. A claim that the surgeon selected or implanted it improperly is a negligence claim against a healthcare provider, and in several of the states involved those claims require pre-suit certification or expert support and run on different deadlines. The two have to be assessed together at the start.

How do you separate the device from my underlying condition?

Through the timeline rather than the diagnosis. The baseline before implantation, the interval during which the device functioned, the onset and character of symptoms, imaging showing wear, migration or fracture, and the findings at revision surgery together establish whether the outcome follows the natural history of the illness or the failure of the hardware. The explanted device examined against that timeline is what makes the distinction concrete.

What should I do now?

Gather the operative reports, the implant log or device identification sticker with the manufacturer, model and lot or serial number, and the imaging. If explant surgery is planned, send written notice to the surgeon and facility asking that the device be preserved and not returned to the manufacturer. If it has already been removed, ask in writing where it is. Those steps are time-sensitive; the rest of the case is not.

About Mr. Sris

Mr. Sris is the owner and founder of Law Offices Of SRIS, P.C., which has practiced since 1997. He is a former prosecutor and is admitted in Virginia, Maryland, the District of Columbia, New Jersey and New York. Of Counsel attorneys contract directly with the firm and handle matters alongside him. In 2019 Mr. Sris testified before the Virginia House Courts of Justice Committee on House Bill 635.

Speak with Mr. Sris

Explanted hardware is commonly returned to the manufacturer or discarded within weeks, and a device claim may also carry the shorter deadlines that apply to claims against healthcare providers. Request a consultation. Reach our location at (888) 437-7747. Consultations are by appointment.

Last reviewed: August 24, 2026.

Attorney Advertising. Law Offices Of SRIS, P.C., principal office: 4008 Williamsburg Court, Fairfax, VA 22032. By appointment. Call (888) 437-7747 to schedule.

The information on this page is general and is not legal advice. No attorney-client relationship is created by reading it or by contacting the firm. Case results depend on a variety of factors unique to each case. Results may vary.

Attorney advertising. Prior results do not guarantee a similar outcome.

Attorney responsible for this advertising: Mr. Sris.